In six decades, two patients have seen a big change in how to manage their Type 1 diabetes.
A gene called TXNIP was the answer, and it led to a drug called verapamil and a successful diabetes trial.
Significant novel findings published by UAB researchers established verapamil as a successful therapeutic approach to target loss of beta cell function caused by Type 1 diabetes.
After experiencing side effects from his obesity on a meaningful vacation, one man seeks medical attention from UAB on his weight loss journey.
A cancer diagnosis was a serious wake-up call for Ragan Cain to become proactive about her health.
